Guest guest Posted December 22, 2010 Report Posted December 22, 2010 News 7 new results for hepatitis c Vertex trims a telaprevir study from its slate of hep C workFierceBiotechVertex ($VRTX) has trimmed one of its ongoing mid-stage studies of the closely-watched hepatitis C drug telaprevir. The developer says it is halting a test ...See all stories on this topic » Inverness hepatitis C victim sets up group to help fellow sufferersAberdeen Press and JournalBy mel fairhurst An Inverness man who contracted hepatitis C after taking drugs has set up a support group for fellow sufferers. ...See all stories on this topic » Vietnamese pharmaceutical firm faces patent lawsuitSGGP... Ho Chi Minh City which makes drugs for the cure of Hepatitis B, has for the first time in Vietnam produced a drug for Hepatitis C in an injection form. ...See all stories on this topic » SGGP How you can helppride source.comServices include HIV education, HIV testing, Hepatitis C testing, harm reduction services, prevention for positives, provider training on HIV and related ...See all stories on this topic » pride source.com Wonderful seriesConcord MonitorMeg Heckman's series on her life with hepatitis C made that impossible. Thanks, Meg, for a wonderful series, for some terrific writing, for making me late ...See all stories on this topic » The TickerBoston HeraldCambridge-based Vertex Pharmaceuticals said it stopped part of a midstage clinical study evaluating a combination of two hepatitis C drugs because it was ...See all stories on this topic » NASDAQ Volume Active Stocks are - ETFC, DVAX, HOLX, MITI, FNSRWall Street BayIts pipeline of product candidate includes HEPLISAV; its Universal Flu vaccine; clinical-stage programs for hepatitis C and hepatitis B therapies, ...See all stories on this topic » Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.